BioQ Pharma has developed a proprietary platform known as invenious™, which revolutionizes the delivery of infusible medicines by transforming them into ready-to-use, connect-and-go systems. This innovative platform aims to enhance the effectiveness, safety, and simplicity of infusible drug administration, ultimately providing greater value to patients, healthcare providers, and payers. The invenious™ system features bespoke delivery solutions that are pre-filled, adaptable, and tailored to specific dosing regimens, making it particularly beneficial for infusible medications that are challenging to prepare or administer. By leveraging this technology, BioQ Pharma seeks to improve existing product claims and introduce new benefits related to the efficiency and safety of drug administration.

The invenious™ connect-and-go portfolio includes a range of products designed for various medical applications, such as post-surgical pain management, anesthesia, sedation, antibiotics, oncology, and biosimilars. Notable examples include the Ropivacaine Readyfusor, which offers a pre-filled infusion solution that is safer and more efficient than traditional fillable pain pumps, and invenious™/propofol, a widely used anesthetic that features programmable flow and bolus capabilities. These products are designed to enhance patient throughput while ensuring improved safety and sterility. BioQ Pharma collaborates with global commercial partners to market these innovative infusible solutions, aiming to reduce the overall cost of care for healthcare providers.

United States

BioQ Pharma is a specialty pharmaceutical company that focuses on setting a new standard of care for infusible drugs.

BioQ Pharma

Company Details